PEA-NBOMe

PEA-NBOMe, also known as N-phenethylamine, is a drug of the phenethylamine and N-benzylphenethylamine families related to phenethylamine. It is the N- derivative of phenethylamine. The drug is a parent compound of the NBOMe family of psychedelic drugs, such as 25I-NBOMe. No data on the pharmacology or toxicity of PEA-NBOMe are available. In any case, based on structure–activity relationships, PEA-NBOMe might produce stimulant and/or hallucinogenic effects. The drug was encountered as a novel designer drug online in 2024. It is not a controlled substance in Canada as of 2025.